RICHTER — Gedeon Richter Share News
0.000.00%
Last trade - 00:00- HUF2.33tn
- HUF2.13tn
- HUF928.96bn
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab
Brief: Hungary's Richter Proposes A Dividend Of 656 Forints Per Share For 2025 -Statement
Brief: Hungary's Richter receives European Commission approval for Fylrevy
Brief: Hungary's Richter acquires women’s health discovery portfolio of U.S.-based Celmatix
Brief: Hungary's Richter says Tuyory received positive opinion from EMA committee
Brief: Richter Announces FY Pharma Sales HUF 914 Billion
Brief: FDA has granted 6-month additional exclusivity for Cariprazine in US, Richter says
Brief: Richter Reports Q1-Q3 Revenue HUF 680.20 Billion
Brief: Hungary's Richter and Hikma receive FDA approval for denosumab biosimilars
Hungary's Richter says some US exports face tariff challenges, but flagship drug exempt (updated)
Brief: Richter Says Pharma Revenues Grew By 11% YoY To HUF 237.5 Billion In Q2 2025
Brief: Hungary's Richter receives European Commission approval for Denosumab biosimilar products Junod and Yaxver
Brief: Hungary's Richter says it voluntarily restricts price of its non-prescription product Panangin